Xponance, Inc. Neurocrine Biosciences Inc Transaction History

Xponance, Inc.

$10.2 Billion
Q3 2024

A detailed history of Xponance, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Xponance, Inc. holds 25,126 shares of NBIX stock, worth $3.15 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,126

Previous 25,228 0.4%

Holding current value

$3.15 Million

Previous $3.47 Million 16.73%

% of portfolio

0.03%

Previous 0.04%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$114.58 - $153.15 $11,687 - $15,621	-102 Reduced 0.4%	25,126 $2.89 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $57,054 - $62,430	-436 Reduced 1.7%	25,228 $3.47 Million
Q1 2024 May 13, 2024	BUY	$130.4 - $143.74 $549,766 - $606,007	4,216 Added 19.66%	25,664 $3.54 Million
Q4 2023 Jan 31, 2024	SELL	$106.07 - $132.76 $99,281 - $124,263	-936 Reduced 4.18%	21,448 $2.83 Million
Q3 2023 Oct 23, 2023	SELL	$94.02 - $117.1 $5,171 - $6,440	-55 Reduced 0.25%	22,384 $2.52 Million
Q2 2023 Jul 13, 2023	SELL	$89.53 - $104.87 $24,978 - $29,258	-279 Reduced 1.23%	22,439 $2.12 Million
Q1 2023 Apr 17, 2023	BUY	$94.11 - $123.02 $36,326 - $47,485	386 Added 1.73%	22,718 $2.3 Million
Q4 2022 Jan 23, 2023	BUY	$106.72 - $127.06 $150,475 - $179,154	1,410 Added 6.74%	22,332 $0
Q3 2022 Oct 24, 2022	BUY	$92.03 - $107.81 $5,245 - $6,145	57 Added 0.27%	20,922 $2.22 Million
Q2 2022 Aug 02, 2022	BUY	$75.79 - $100.07 $40,699 - $53,737	537 Added 2.64%	20,865 $2.03 Million
Q1 2022 Apr 20, 2022	SELL	$72.45 - $94.81 $6,665 - $8,722	-92 Reduced 0.45%	20,328 $1.91 Million
Q4 2021 Jan 31, 2022	SELL	$79.65 - $106.22 $2,867 - $3,823	-36 Reduced 0.18%	20,420 $1.74 Million
Q3 2021 Nov 05, 2021	SELL	$86.18 - $99.03 $13,702 - $15,745	-159 Reduced 0.77%	20,456 $1.96 Million
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $102,486 - $117,201	1,146 Added 5.89%	20,615 $2.01 Million
Q1 2021 May 10, 2021	BUY	$87.57 - $119.4 $870,270 - $1.19 Million	9,938 Added 104.27%	19,469 $1.89 Million
Q4 2020 Feb 11, 2021	SELL	$86.91 - $108.33 $8,343 - $10,399	-96 Reduced 1.0%	9,531 $914,000
Q3 2020 Oct 26, 2020	BUY	$96.16 - $135.15 $9,039 - $12,704	94 Added 0.99%	9,627 $926,000
Q2 2020 Aug 14, 2020	BUY	$85.09 - $130.36 $811,162 - $1.24 Million	9,533 New	9,533 $1.16 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.

Account